For Pilar DeMann, being on semaglutide during perimenopause motivated her to prioritize whole foods, stay mindful of portion sizes, and scale back on alcohol.
New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.
A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes med ...
As previously reported in Women’s Health, semaglutide injections mimic the effects of a hormone called glucagon-like ...
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...
GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...
Key TakeawaysTwo new studies shed light on the costs associated with newer weight loss drugs and their use before bariatric ...
Semaglutide and tirzepatides, the active ingredients in drugs including Mounjaro and Ozempic, have been hailed as a ...
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...
A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback